cholic acid and cgp-56697

cholic acid has been researched along with cgp-56697 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kesselheim, AS; Maggs, LR; Sarpatwari, A	1

Other Studies

1 other study(ies) available for cholic acid and cgp-56697

Article	Year
Experience With the Priority Review Voucher Program for Drug Development. JAMA, 2015, Oct-27, Volume: 314, Issue:16 Topics: Antibodies, Monoclonal; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Antitubercular Agents; Artemether, Lumefantrine Drug Combination; Artemisinins; Cholic Acid; Chondroitinsulfatases; Diarylquinolines; Drug Approval; Drug Combinations; Drug Industry; Ethanolamines; Fluorenes; Humans; Neglected Diseases; Phosphorylcholine; Program Development; Rare Diseases; United States; United States Food and Drug Administration	2015

Article

Year

Experience With the Priority Review Voucher Program for Drug Development.

JAMA, 2015, Oct-27, Volume: 314, Issue:16

Topics: Antibodies, Monoclonal; Antimalarials; Antineoplastic Agents; Antiprotozoal Agents; Antitubercular Agents; Artemether, Lumefantrine Drug Combination; Artemisinins; Cholic Acid; Chondroitinsulfatases; Diarylquinolines; Drug Approval; Drug Combinations; Drug Industry; Ethanolamines; Fluorenes; Humans; Neglected Diseases; Phosphorylcholine; Program Development; Rare Diseases; United States; United States Food and Drug Administration

2015